CN115124466B - 一种四氢罂粟碱盐酸盐的合成方法 - Google Patents
一种四氢罂粟碱盐酸盐的合成方法 Download PDFInfo
- Publication number
- CN115124466B CN115124466B CN202210850391.0A CN202210850391A CN115124466B CN 115124466 B CN115124466 B CN 115124466B CN 202210850391 A CN202210850391 A CN 202210850391A CN 115124466 B CN115124466 B CN 115124466B
- Authority
- CN
- China
- Prior art keywords
- reaction
- tetrahydropapaverine
- hydrochloride
- cyclization
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VMPLLPIDRGXFTQ-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline;hydrochloride Chemical compound [Cl-].C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CC[NH2+]1 VMPLLPIDRGXFTQ-UHFFFAOYSA-N 0.000 title claims abstract description 30
- 238000001308 synthesis method Methods 0.000 title claims abstract description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims abstract description 75
- 238000000034 method Methods 0.000 claims abstract description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 50
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 43
- 238000006243 chemical reaction Methods 0.000 claims abstract description 42
- ANOUKFYBOAKOIR-UHFFFAOYSA-N 3,4-dimethoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1OC ANOUKFYBOAKOIR-UHFFFAOYSA-N 0.000 claims abstract description 39
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 33
- WUAXWQRULBZETB-UHFFFAOYSA-N homoveratric acid Chemical compound COC1=CC=C(CC(O)=O)C=C1OC WUAXWQRULBZETB-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000005580 one pot reaction Methods 0.000 claims abstract description 31
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 21
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 15
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 15
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 12
- 239000003795 chemical substances by application Substances 0.000 claims abstract 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 36
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 34
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 22
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 22
- 238000011065 in-situ storage Methods 0.000 claims description 16
- UCJDFFOXXPPGLJ-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydroisoquinoline Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NCCC2=CC(OC)=C(OC)C=C12 UCJDFFOXXPPGLJ-UHFFFAOYSA-N 0.000 claims description 15
- 238000010494 dissociation reaction Methods 0.000 claims description 15
- 230000005593 dissociations Effects 0.000 claims description 15
- FYGHSUNMUKGBRK-UHFFFAOYSA-N 1,2,3-trimethylbenzene Chemical compound CC1=CC=CC(C)=C1C FYGHSUNMUKGBRK-UHFFFAOYSA-N 0.000 claims description 12
- YXWQTVWJNHKSCC-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1 YXWQTVWJNHKSCC-UHFFFAOYSA-N 0.000 claims description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 7
- 238000006482 condensation reaction Methods 0.000 claims description 7
- 238000006297 dehydration reaction Methods 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- 229910052700 potassium Inorganic materials 0.000 claims description 7
- 238000006722 reduction reaction Methods 0.000 claims description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 6
- 230000018044 dehydration Effects 0.000 claims description 6
- 239000008096 xylene Substances 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- 238000010189 synthetic method Methods 0.000 claims description 3
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims description 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 claims description 2
- 229920000137 polyphosphoric acid Polymers 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 238000000605 extraction Methods 0.000 abstract description 7
- 239000000543 intermediate Substances 0.000 abstract description 6
- 238000000926 separation method Methods 0.000 abstract description 4
- 238000000746 purification Methods 0.000 abstract description 2
- 238000004090 dissolution Methods 0.000 abstract 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 36
- 239000012535 impurity Substances 0.000 description 36
- 239000012071 phase Substances 0.000 description 23
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 239000008346 aqueous phase Substances 0.000 description 11
- 239000002994 raw material Substances 0.000 description 11
- 239000011259 mixed solution Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 239000012065 filter cake Substances 0.000 description 7
- LRUSBWIBSILYNE-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydroisoquinoline;hydrochloride Chemical compound [Cl-].C1=C(OC)C(OC)=CC=C1CC1=[NH+]CCC2=CC(OC)=C(OC)C=C12 LRUSBWIBSILYNE-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- XXZSQOVSEBAPGS-UHFFFAOYSA-L atracurium besylate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1.[O-]S(=O)(=O)C1=CC=CC=C1.C1=C(OC)C(OC)=CC=C1CC1[N+](CCC(=O)OCCCCCOC(=O)CC[N+]2(C)C(C3=CC(OC)=C(OC)C=C3CC2)CC=2C=C(OC)C(OC)=CC=2)(C)CCC2=CC(OC)=C(OC)C=C21 XXZSQOVSEBAPGS-UHFFFAOYSA-L 0.000 description 4
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229960002945 atracurium besylate Drugs 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003158 myorelaxant agent Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- -1 1, 5-pentanediol acrylic ester Chemical class 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229950008951 atracurium besilate Drugs 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229960000970 cisatracurium besylate Drugs 0.000 description 1
- XXZSQOVSEBAPGS-DONVQRBFSA-L cisatracurium besylate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1.[O-]S(=O)(=O)C1=CC=CC=C1.C1=C(OC)C(OC)=CC=C1C[C@H]1[N@+](CCC(=O)OCCCCCOC(=O)CC[N@+]2(C)[C@@H](C3=CC(OC)=C(OC)C=C3CC2)CC=2C=C(OC)C(OC)=CC=2)(C)CCC2=CC(OC)=C(OC)C=C21 XXZSQOVSEBAPGS-DONVQRBFSA-L 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- CZXGXYBOQYQXQD-UHFFFAOYSA-N methyl benzenesulfonate Chemical compound COS(=O)(=O)C1=CC=CC=C1 CZXGXYBOQYQXQD-UHFFFAOYSA-N 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210850391.0A CN115124466B (zh) | 2022-07-19 | 2022-07-19 | 一种四氢罂粟碱盐酸盐的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210850391.0A CN115124466B (zh) | 2022-07-19 | 2022-07-19 | 一种四氢罂粟碱盐酸盐的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115124466A CN115124466A (zh) | 2022-09-30 |
CN115124466B true CN115124466B (zh) | 2024-01-12 |
Family
ID=83384136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210850391.0A Active CN115124466B (zh) | 2022-07-19 | 2022-07-19 | 一种四氢罂粟碱盐酸盐的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115124466B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115677579B (zh) * | 2022-11-02 | 2024-05-24 | 上海药坦药物研究开发有限公司 | 四氢罂粟碱及其中间体的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101544603A (zh) * | 2009-05-05 | 2009-09-30 | 南京威尔化工有限公司 | 3,4-二氢罂粟碱及其盐酸盐的制备方法 |
CN105541714A (zh) * | 2015-12-16 | 2016-05-04 | 浙江普洛康裕制药有限公司 | 一种罂粟碱及盐酸罂粟碱的制备方法 |
CN112920116A (zh) * | 2019-12-06 | 2021-06-08 | 上海医药工业研究院 | 一种罂粟碱的制备方法 |
-
2022
- 2022-07-19 CN CN202210850391.0A patent/CN115124466B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101544603A (zh) * | 2009-05-05 | 2009-09-30 | 南京威尔化工有限公司 | 3,4-二氢罂粟碱及其盐酸盐的制备方法 |
CN105541714A (zh) * | 2015-12-16 | 2016-05-04 | 浙江普洛康裕制药有限公司 | 一种罂粟碱及盐酸罂粟碱的制备方法 |
CN112920116A (zh) * | 2019-12-06 | 2021-06-08 | 上海医药工业研究院 | 一种罂粟碱的制备方法 |
Non-Patent Citations (2)
Title |
---|
One-Pot Synthesis of Papaverine Hydrochloride and Identification of Impurities;Yu, Wen-Shuai等;Russian Journal of Organic Chemistry;第第56卷卷(第第7期期);1295-1299 * |
Synthesis of (±)-glaucine and (±)-neospirodienone via an one-pot Bischler-Napieralski reaction and oxidative coupling by a hypervalent iodine reagent;Huang, Wei-Jan等;Helvetica Chimica Acta;第第87卷卷(第第1期期);167-174 * |
Also Published As
Publication number | Publication date |
---|---|
CN115124466A (zh) | 2022-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115124466B (zh) | 一种四氢罂粟碱盐酸盐的合成方法 | |
CN105348172A (zh) | (s)-1-(4-甲氧基-3-乙氧基)苯基-2-甲磺酰基乙胺的制备及阿普斯特的制备方法 | |
CN113292569A (zh) | 一种jak抑制剂的制备方法 | |
CN112062767A (zh) | 一种卢美哌隆的制备方法及其中间体 | |
KR20040072711A (ko) | 펜세린 및 그 유사체의 제조방법 | |
CN115160148A (zh) | 一种高选择性的合成n-烯丙基苄胺的方法 | |
CN111517975B (zh) | 一种2-氨基-5-氯-n,3-二甲基苯甲酰胺的制备方法 | |
CN116120163B (zh) | 一种贝派地酸的合成方法及其中间体 | |
CN111170847A (zh) | 一种制备盐酸屈他维林中间体的新方法 | |
CN114349711B (zh) | 一种(R)-1-Boc-3-羟甲基哌嗪的合成方法 | |
CN111217709A (zh) | 一种(1-氟环丙基)甲胺盐酸盐的制备方法 | |
CN113735760B (zh) | 一种盐酸罗哌卡因的制备方法 | |
CN113527250B (zh) | 辛波莫德中间体及其制备方法 | |
CN114989103B (zh) | 一种2-甲氧基-3-(1-甲基-1h-1,2,4-***-3-基)苯胺的制备方法 | |
CN110835319B (zh) | 一种贝那普利中间体和贝那普利盐酸盐的合成方法 | |
CN114195684B (zh) | 一种氨基保护基n-取代手性氨基酸的合成方法 | |
CN113121414B (zh) | 一种曲格列汀中间体的合成方法 | |
CN110483402B (zh) | 一种3-溴-5-苯基-1h-吡唑的合成方法 | |
CA2372763C (en) | New process | |
CN106749053B (zh) | 氯甲西泮重排产物的制备方法 | |
WO2009145368A1 (en) | Improved preparing method of (s)-omeprazole from omeprazole racemate using optical resolution agent | |
CN108101842B (zh) | 一种2-羟基-4-羧基喹啉的制备方法 | |
CN114835714A (zh) | 一种托法替尼的制备方法 | |
KR101325589B1 (ko) | 1-알킬-2-(2-아미노에틸)피롤리딘의 제조방법 | |
CN117247360A (zh) | 一种2-甲氧基-3-(1-甲基-1h-1,2,4-***-3-基)苯胺的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230116 Address after: 311404 standard plant, No. 33, Beishan Road Branch Road, Xindeng Town, Fuyang District, Hangzhou City, Zhejiang Province Applicant after: Shisenhai (Hangzhou) biopharmaceutical Co.,Ltd. Applicant after: Shanghai Pharmaceutical Industry Research Institute Co.,Ltd. Address before: Standard workshop, No. 33, Beishan Road, Xindeng Town, Fuyang District, Hangzhou City, Zhejiang Province Applicant before: Shisenhai (Hangzhou) biopharmaceutical Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
CB02 | Change of applicant information |
Address after: 311404 standard plant, No. 33, Beishan Road Branch Road, Xindeng Town, Fuyang District, Hangzhou City, Zhejiang Province Applicant after: Zhejiang Boxiao Biopharmaceutical Co.,Ltd. Applicant after: Shanghai Pharmaceutical Industry Research Institute Co.,Ltd. Address before: 311404 standard plant, No. 33, Beishan Road Branch Road, Xindeng Town, Fuyang District, Hangzhou City, Zhejiang Province Applicant before: Shisenhai (Hangzhou) biopharmaceutical Co.,Ltd. Applicant before: Shanghai Pharmaceutical Industry Research Institute Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |